已收盤 07-25 16:00:00 美东时间
+0.000
+0.71%
NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and
2024-09-25 20:30
The option agreement grants NLS Pharmaceutics Ltd. the exclusive option to in-l...
2023-12-01 08:30
Professor Claudio L. A. Bassetti, MD, is the Chair, Neurology Department, Insel...
2023-11-28 08:30
NLS to Webcast its Event on Thursday, July 6, 2023, at 11:00 am ET ZURICH, SWIT...
2023-06-30 20:00
ZURICH, SWITZERLAND / ACCESSWIRE / January 11, 2023 / NLS Pharmaceutics Ltd. (N...
2023-01-11 21:32
NLS Pharmaceutics AG (NASDAQ:NLSPW – Get Rating) was the target of a large drop...
2022-07-16 21:51
Since the interim results were released in March, patient enrollment has nearly...
2022-05-04 21:08
Even when a business is losing money, it's possible for shareholders to make mo...
2021-09-30 23:55
Even when a business is losing money, it's possible for shareholders to make mo...
2021-09-30 23:55
Published: 09/28/2021NLSP STANS, SWITZERLAND / ACCESSWIRE / September 28, 2021...
2021-09-28 12:30